2019 Membership Renewal
Patients Report Greater Sexual Satisfaction with BPH Drug Combination
Happy New Year!
We would like to again thank you for your continued support and loyalty to the International Society for Sexual Medicine. It is you, the membership community, who drives and shapes the ISSM.
In order to ensure that you will have uninterrupted access to all of ISSM's membership benefits, including the Journal of Sexual Medicine, we kindly ask you to pay your ISSM membership dues for 2019 in a timely manner either through one of our affiliated societies or directly with us through our website's Members Only page.
Just click on your profile page to view the invoice section. While you're there, please take a moment to update your contact information, if it has changed.
Of course, if you have already paid your membership dues, we thank you.
Men with benign prostatic hyperplasia (BPH) with lower urinary tract symptoms (LUTS) might have improvements in sexual satisfaction by taking a combination of dutasteride and solifenacin.
A recent Journal of Sexual Medicine study reported that men who took 0.5 mg of dutasteride and 20 mg of solifenacin had higher rates of sexual function satisfaction compared to men who took dutasteride alone or dutasteride with 10 mg of solifenacin.
The men took the medications once daily for six months.
All 317 men in the study saw their urinary symptoms improve from baseline, regardless of the doses they took. Erectile function did not change, and ejaculatory function was "fractionally" decreased.
Forty-one men dropped out of the study, however. The authors called for more research.
See more details here.